You are here: Home > Activities > Collaborations > IRDiRC
Collaboration

IRDiRC

Objectives 2020: 200 new therapies for rare diseases and means to diagnose most rare diseases

www.irdirc.org

The International Rare Diseases Research Consortium (IRDiRC) teams up researchers and organizations investing in rare diseases research in order to achieve two main objectives by the year 2020, namely to deliver 200 new therapies for rare diseases and means to diagnose most rare diseases. ENERCA, in addition to collaborating with IRDiRC in events and providing relevant information on rare anaemias, includes relevant news about this initiative on its news (Ex: section and Newsletters and promotes events like the IRDiRC Shenzhen Conference).

Copyright © 2002 - 2017 Enerca

Co-funded by the Health Programme of the European Union.